Actively Recruiting
Feasibility Study of a New Immunoglobulin E (IgE) Assay Method
Led by University Hospital, Toulouse · Updated on 2026-03-19
1376
Participants Needed
2
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main objective is to study the feasibility of a new specific IgE assay using a bioluminescence technique in a pediatric and adult allergic population. For this, we will collect blood, and urine during a blood test scheduled for the follow-up of the patient.
CONDITIONS
Official Title
Feasibility Study of a New Immunoglobulin E (IgE) Assay Method
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males or females 6 months old or older
- Sensitized or allergic to a food allergen, airborne allergen, hymenoptera venom, or drug confirmed by positive skin test, specific IgE > 0.1 kUA/L, or history of IgE-mediated allergic reaction
- Up-to-date social coverage
You will not qualify if you...
- Children younger than 6 months old
- Children weighing less than 10 kg
- Pregnant or breastfeeding women
- Patients with cystic fibrosis
- Patients with immune system or autoimmune diseases
- History of delayed or contact allergy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
University Hospital
Toulouse, France, 31000
Actively Recruiting
2
Larrey hospital
Toulouse, France, 31059
Actively Recruiting
Research Team
M
Marine Michelet, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here